Filter
2930
Filtered Results: 2930
Text search:
drug
market
Featured
Recommendations
260
New Publications
815
Language
Document type
No document type
1716
Studies & Reports
491
Guidelines
380
Manuals
132
Strategic & Response Plan
112
Fact sheets
38
Training Material
35
Situation Updates
10
Resource Platforms
7
Infographics
6
Brochures
1
App
1
Online Courses
1
Countries / Regions
India
197
Global
116
Kenya
99
Uganda
80
Ethiopia
80
Nigeria
66
South Africa
65
Western and Central Europe
61
Ghana
50
Sierra Leone
49
Liberia
48
Malawi
47
Bangladesh
47
Nepal
46
Myanmar / Burma
46
Tanzania
45
Zambia
42
Rwanda
37
Africa
36
Latin America and the Carribbean
36
South–East Asia Region
31
Philippines
30
Namibia
29
Zimbabwe
27
Ukraine
25
Eastern Europe
23
Lesotho
21
Cambodia
21
Congo, Democratic Republic of
21
Indonesia
19
Syria
18
Asia
18
Botswana
18
Russia
15
Senegal
12
Mozambique
12
Eswatini/ Swaziland
11
Burkina Faso
10
Venezuela
10
East and Southern Africa
10
Brazil
10
USA
9
Middle East and North Africa
9
Eastern Europe and Central Asia
9
Thailand
8
Cameroon
8
Albania
8
Guinea
8
West and Central Africa
8
Georgia
8
South Sudan
8
Germany
7
Laos
6
Haiti
6
Vietnam
6
Sudan
6
Tajikistan
5
Colombia
5
China
5
North America
5
Mexico
4
Western Pacific Region
4
Lebanon
4
Sri Lanka
4
Central African Republic
4
Libya
4
Iraq
4
North Macedonia
3
Timor Leste/ East Timor
3
Benin
3
Iran
3
Peru
3
Jordan
3
Paraguay
3
Papua New Guinea
3
Moldova
3
Bhutan
3
Somalia
3
Pakistan
3
Turkey
2
Chile
2
Fiji
2
Kyrgyzstan
2
Afghanistan
2
Morocco
2
Hungary
2
Tunisia
2
Argentina
2
Yemen
2
Palestine
2
Poland
2
Mali
2
North Korea
1
Serbia
1
Gambia
1
Kazakhstan
1
Canada
1
Estonia
1
Uzbekistan
1
Qatar
1
Bulgaria
1
Italy
1
Armenia
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Jamaica
1
Denmark
1
Maldives
1
Mauritius
1
Norway
1
Portugal
1
Bolivia
1
Greece
1
Angola
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1203
Clinical Guidelines
251
Public Health
159
Women & Child Health
89
Key Resources
87
Pharmacy & Technologies
47
Capacity Building
35
Toolboxes
HIV
300
Mental Health
291
TB
190
AMR
176
Pharmacy
143
COVID-19
119
NTDs
101
NCDs
71
Caregiver
50
Rapid Response
42
Planetary Health
40
Conflict
38
Ebola & Marburg
37
Refugee
35
Global Health Education
34
Health Financing Toolbox
30
Disability
29
Natural Hazards
13
Cholera
13
Specific Hazards
10
Malaria
8
Social Ethics
7
Polio
7
Zika
4
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are ...
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o...
PLOS Glob Public Health 4(12): e0004035. https://doi. org/10.1371/journal.pgph.0004035.
A new formulation of praziquantel, arpraziquantel (arPZQ), has been developed for preschool-
aged children (PSAC) to fill the treatment gap for this age group in schistosomiasis control and
elimination program...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Thailand and Viet Nam)
Migrants and mobile popul...
Migrants and mobile popul...
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo...
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ...
Antimicrobial resistance (AMR) both in human and veterinary medicine has reached alarming levels in
most parts of the world and has now been recognized as a significant emerging threat to global public
health and food security. In June 2015, the Food and Agriculture Organization of the United Nati...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
State of Health in the WHO African Region
recommended
This report is not a country scorecard. Rather, its purpose is to act as a compass to guide progress towards health in the SDGs.
There has been a significant improvement in the state of health in the region with healthy life expectancy - time spent in full health - in the region increasing from 50...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
The goal of this addendum is to help management and staff
minimize the risk of TB transmission at facilities in resource limited settings in which a.) HIV-infected persons receive diagnosis, care, treatment,
and/or support, and b.) there is a high prevalence of HIV infection, both known
and...
MSF Essential Drugs - Practical Guidelines 2022
recommended
Practical guide intended for physicians, pharmacists, nurses and medical auxiliaries. This guide is not a dictionary of pharmacological agents. It is a practical manual intended for health professionals, physicians, pharmacists, nurses and health auxiliaries invoved in curative care and drug managem...
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa...
The Global Programme on Tuberculosis & Lung Health of the World Health Organization (WHO/GTB) is now combining all current recommendations into one overall set of consolidated guidelines on TB. The guidelines contain recommendations pertaining to all areas related to the programmatic management of T...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
